← Open Payments lookup

DONALD DIEFENDORF: Open Payments

NPI 1437187002 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$859 in 39 payments from 10 companies in 2025. Trend: 2023 $520 · 2024 $565 · 2025 $859

Food & beverage: $859
CompanyPaymentsAmount
Novo Nordisk Inc9$189
AstraZeneca Pharmaceuticals LP8$184
Exact Sciences Corporation5$113
Lilly USA, LLC5$95
PFIZER INC.4$93
Bayer Healthcare Pharmaceuticals Inc.3$85
Merck Sharp & Dohme LLC2$36
Philips North America LLC1$23
Paratek Pharmaceuticals, Inc.1$21
Sumitomo Pharma America, Inc.1$19

Products named: Ozempic, BREZTRI, MOUNJARO, Kerendia, Cologuard Collection Kit, AIRSUPRA, PREVNAR 20, CAPVAXIVE.

Industry payments across MD — which companies pay providers there.